Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium

By sjmartinez • March 21, 2025

Kishan AU, Sun Y, Tree AC, Hall E, Dearnaley D, Catton CN, Lukka HR, Pond G, Lee WR, Sandler HM, Feng FY, Nguyen PL, Incrocci L, Heemsbergen W, Pos FJ, Horwitz E, Wong JK, Hoffman KE, Hassanzadeh C, Kuban DA, Arcangeli S, Sanguineti G, Supiot S, Crehange G, Latorzeff I, Kalbasi TR, Steinberg ML, Valle LF, Loblaw A, Nikitas J, Roy S, Zaorsky NG, Jia AY, Spratt DE. Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium. Lancet Oncol. 2025 Mar 17:S1470-2045(25)00034-8. doi: 10.1016/S1470-2045(25)00034-8. Epub ahead of print. PMID: 40112848.

Tags: DOM STAT, General Internal Medicine, Publications

The State of VA-funded Women Veterans’ Health Systems Research

Borsky AE, Kroll-Desrosiers A, Rodriguez A, Fenwick K, Friedman JK, Yano EM. The State of VA-funded Women Veterans' Health Systems Research. Womens Health Issues. 2025[...]

CRE25-050: Durable Response to Immunotherapy Rechallenge With Double Immunotherapy for a Patient With Advanced Non-Small Cell Lung Cancer

Huynh JT, Li R, Shin DS. CRE25-050: Durable Response to Immunotherapy Rechallenge With Double Immunotherapy for a Patient With Advanced Non-Small Cell Lung Cancer. J[...]

Clinical Telavancin Failure in Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia

Dao KT, D'Assumpcao C, Sharma R, Singh C, Kuran R, Heidari A. Clinical Telavancin Failure in Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia. Cureus. 2025 Feb 24;17(2):e79588.[...]